Test Price
2,000 AED✅ Home Collection Available
Immunosuppressant Drug Profile 1 in UAE | 2,000 AED | DHA Licensed Therapeutic Drug Monitoring
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Daily 8 AM – 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation by a licensed General Practitioner.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Core Metrics at a Glance
LC-MS/MS gold-standard quantification of trough immunosuppressant levels. Same-day reporting when sample is received by 5 PM. Full insurance pre-verification and post-test physician tele-consultation included.
Test Overview & Methodology
The Immunosuppressant Drug Profile 1 is a precise LC-MS/MS blood test that measures trough levels of key immunosuppressive medications (e.g., tacrolimus, cyclosporine, sirolimus, everolimus) to prevent toxicity and organ rejection in transplant recipients. This therapeutic drug monitoring (TDM) panel enables your clinician to fine-tune dosing with high specificity and no cross-reactivity from metabolites.
| Feature | Our Test (Premium) | Routine Lab Alternative |
|---|---|---|
| Methodology | LC-MS/MS (Gold Standard) | Immunoassay / HPLC |
| Turnaround Time | Same-day report (sample by 5 PM) | 24–48 hours |
| Price (AED) | 2,000 | 1,200–1,500 |
| Precision for Trough Levels | High specificity, no cross-reactivity | Possible metabolite interference |
| Home Collection | Included (VIP Phlebotomy, 8 AM–11 PM) | Not available |
Physician Insight & Safety Protocols
"Therapeutic drug monitoring for immunosuppressants is a critical pillar of post-transplant care. The LC-MS/MS method provides the resolution needed to distinguish active drug from interfering metabolites, giving clinicians confidence when adjusting doses. Always report your exact last dose time and any new symptoms to your transplant team." — Dr. Ajay Singh (DHA Registration ID: 36234132), General Practitioner, DNA Labs UAE.
Medication Safety Advisory
Do not discontinue, skip, or alter your prescribed immunosuppressant medication without direct instruction from your treating physician. Abrupt changes may trigger acute organ rejection, severe toxicity, or life-threatening complications.
Exclusion Criteria & Emergency Red Flags
- Home Collection Exclusion: Patients with known coagulation disorders, active bleeding, or those on high-dose anticoagulants require a hospital-based venipuncture.
- Red Flags (Seek Emergency Care Immediately): New-onset severe tremors, confusion, seizures, severe headache, sudden decrease in urine output, jaundice, or graft tenderness/pain.
- Critical Pre-Test Instruction: All samples must be collected at trough level — immediately before the next scheduled dose. Inaccurate timing can render the result clinically uninterpretable.
Patient FAQ & Clinical Guidance
1. What is the Immunosuppressant Drug Profile 1 and why is it necessary?
This blood test quantifies the exact concentration of your immunosuppressant medication at trough level, ensuring the dose is both effective against organ rejection and safe from toxicity. It is routinely ordered after kidney, liver, heart, or other solid organ transplants to guide precision dosing and minimize long-term complications.
2. How should I prepare for the blood draw to ensure accurate results?
You must provide the exact time and amount of your last medication dose. The blood sample must be collected at trough — just before your next scheduled dose. Fasting is not typically required; however, consistent timing relative to your dosing schedule is essential for valid interpretation.
3. What do the results mean for my ongoing treatment plan?
Results indicate whether your drug level lies within the established therapeutic window: levels above the range increase toxicity risk, while levels below raise the chance of organ rejection. Your transplant physician will integrate these results with your clinical status, renal function, and biopsy findings to adjust your regimen safely.
UAE Regulatory & Data Privacy Adherence
DHA Facility License No. 1143 | ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139)
DNA Labs UAE strictly complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All patient data is encrypted, access-controlled, and processed solely for diagnostic purposes. Clinical safety and patient consent are governed under Federal Decree-Law No. 4 of 2016 on Medical Liability.
Contact us: +971 54 548 8731 | WhatsApp: Click to chat
Clinical & Logistical Metadata
| Test Name | Immunosuppressant Drug Profile 1 (TDM Panel – LC-MS/MS) |
| Price (AED) | 2,000 |
| Turnaround Time | Same-day report (sample received by 5 PM) |
| Sample Type / Matrix | Peripheral Whole Blood (trough draw) |
| Methodology Used | LC-MS/MS (Liquid Chromatography–Tandem Mass Spectrometry) |
| ICD-10-CM Code | Z51.81 |
| LOINC Code | 96369-3 |
| DHA Facility License & Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE – DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians